Randy L. Luciano

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

Jonathan Barratt, Richard Lafayette, Jens Kristensen et al. · Kidney International · 2022 · 215 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +13

Urine TNF-α and IL-9 for clinical diagnosis of acute interstitial nephritis

Dennis G. Moledina, F. Perry Wilson, Jordan S. Pober et al. · JCI Insight · 2019 · 150 citations · Full text

Medicine, Immunology, Nephrology +17

Carboxy Terminus of Human Herpesvirus 8 Latency-Associated Nuclear Antigen Mediates Dimerization, Transcriptional Repression, and Targeting to Nuclear Bodies

David R. Schwam, Randy L. Luciano, Shahana S. Mahajan et al. · Journal of Virology · 2000 · 146 citations

Life Sciences, Cell Biology, Infectious Diseases +15

Risk of Poor Outcomes with Novel and Traditional Biomarkers at Clinical AKI Diagnosis

Isaac E. Hall, Steven G. Coca, Mark A. Perazella et al. · Clinical Journal of the American Society of Nephrology · 2011 · 118 citations

Medicine, Nephrology, Kidney Transplantation +15

Kidney Biopsy–Related Complications in Hospitalized Patients with Acute Kidney Disease

Dennis G. Moledina, Randy L. Luciano, Lidiya Kukova et al. · Clinical Journal of the American Society of Nephrology · 2018 · 88 citations · Full text

Medicine, Internal Medicine, Nephrology +12